Annual Working Capital
$756.50 M
+$459.60 M+154.80%
December 31, 2024
Summary
- As of March 12, 2025, NAMS annual working capital is $756.50 million, with the most recent change of +$459.60 million (+154.80%) on December 31, 2024.
- During the last 3 years, NAMS annual working capital has risen by +$701.02 million (+1263.74%).
- NAMS annual working capital is now at all-time high.
Performance
NAMS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$756.50 M
+$359.88 M+90.74%
December 31, 2024
Summary
- As of March 12, 2025, NAMS quarterly working capital is $756.50 million, with the most recent change of +$359.88 million (+90.74%) on December 31, 2024.
- Over the past year, NAMS quarterly working capital has increased by +$359.88 million (+90.74%).
- NAMS quarterly working capital is now at all-time high.
Performance
NAMS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NAMS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +154.8% | +90.7% |
| 3 y3 years | +1263.7% | +90.7% |
| 5 y5 years | +10000.0% | +90.7% |
NAMS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1263.7% | at high | +1263.7% |
| 5 y | 5-year | at high | >+9999.0% | at high | +1263.7% |
| alltime | all time | at high | >+9999.0% | at high | +1263.7% |
NewAmsterdam Pharma Company NV Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $756.50 M(+154.8%) | $756.50 M(+90.7%) |
| Sep 2024 | - | $396.62 M(-0.9%) |
| Jun 2024 | - | $400.05 M(-6.6%) |
| Mar 2024 | - | $428.10 M(+44.2%) |
| Dec 2023 | $296.89 M | $296.89 M(-22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $381.37 M(-13.7%) |
| Dec 2022 | $441.92 M(+696.7%) | $441.92 M(+121.4%) |
| Jun 2022 | - | $199.57 M(+259.8%) |
| Dec 2021 | $55.47 M(-1356.6%) | $55.47 M |
| Dec 2020 | -$4.41 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual working capital?
- What is the all time high annual working capital for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual working capital year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly working capital?
- What is the all time high quarterly working capital for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly working capital year-on-year change?
What is NewAmsterdam Pharma Company NV annual working capital?
The current annual working capital of NAMS is $756.50 M
What is the all time high annual working capital for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual working capital is $756.50 M
What is NewAmsterdam Pharma Company NV annual working capital year-on-year change?
Over the past year, NAMS annual working capital has changed by +$459.60 M (+154.80%)
What is NewAmsterdam Pharma Company NV quarterly working capital?
The current quarterly working capital of NAMS is $756.50 M
What is the all time high quarterly working capital for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly working capital is $756.50 M
What is NewAmsterdam Pharma Company NV quarterly working capital year-on-year change?
Over the past year, NAMS quarterly working capital has changed by +$359.88 M (+90.74%)